The Gross Margin of Guizhou Sanli Pharmaceutical Co Ltd (603439.SS) is 69.43%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
| Date | Value |
|---|---|
| 2023-12-31 | 69.43% |
| 2022-12-31 | 71.74% |
| 2021-12-31 | 70.49% |
| 2020-12-31 | 66.84% |
| 2019-12-31 | 66.19% |
| 2018-12-31 | 65.42% |
| 2017-12-31 | 66.44% |
| 2016-12-31 | 65.04% |
| 2015-12-31 | 62.23% |
| 2014-12-31 | 60.58% |